但目前尚不清楚,在缺乏 HER2靶向治疗的情况下,对于诊断为pT1aN0M0 HER2+乳腺癌患者(浸润灶大小≤5 mm)是否需要辅助全身治疗。近期,一项发布在《Cancer》杂志上的研究,通过分析美国国家癌症数据库(National Cancer Database, NCDB)数据,试图...
Adjuvant chemotherapy of pT1a and pT1b breast carcinoma:results from the NEMESI study[J].{H}BMC Cancer,2012,(12):158.Gori S, Clavarezza M, Siena S, Foglietta J, Tarenzi E, Giordano M, Molino A, Graiff C, Fusco V, Alabiso O, Baldini E, Gamucci T, Altavilla G, Dondi D, ...
It is possible that small cases, although invasive, did not undergone sufficient mytotic cycles to produce the sequence of genetic changes that characterize the no return phase of breast cancer. A 17% of pT1a and pT1b cases displayed lymph node metastases (mean 26 lymph-node/case examined):...
P2-12-16: HER2 Expression Is the Major Risk Factor for Recurrence in pT1a-b,N0 Breast Cancer: A French Regional Population-Based Study of 671 Patients. Background: To evaluate the prognostic impact of HER2 overexpression in patients with pT1a-b, node negative, breast cancers.Patients and ...
The relation between oestrogen receptor status of primary breast cancer as determined immuncytochemically on fine-needle aspirates and the response to tamo... RC Smith - 《Lancet》 被引量: 65发表: 1996年 A motivational interviewing course for pharmacy students. To create, implement, and evaluate...
Breast cancerInterval cancer riskAlthough outcomes for women with breast cancers may vary by biologic subtype, patients with T1a,b N0M0 tumors have an excellent prognosis across all subgroups. HER2 overexpression occurs in 15-20% of primary breast tumors, and is associated with diminished disease-...
breast cancerprognosissurvivalT1aN0M0Patients with early breast cancer are considered to have a good prognosis. However, the published literature regarding long-term survival in these cases is limited. This study examined long-term survival, as well as prognostic factors, in patients treated for pT...
Breast cancerPT1a/b pN0PrognosisThe prognosis of infracentimetric breast cancers (BC) is heterogeneous. The EURISTIC survey describes how French oncology specialists perceive the prognosis of pT1a,b pN0 BCs. A self-administered questionnaire has been sent to over 2000 French BC specialists. Six ...
Malignant neoplasm of breast他莫昔芬复发PURPOSE: To evaluate if in low-risk breast cancer patients (pT1a-pT1b, pN0) tamoxifen can reduce local recurrence and improve survival. METHODS: Retrospectively 700 patients were analyzed. All patients were treated from 1980 to 2003 with conservative surgery...
Do multifocal or multicentric pT1a nodenegative HER2+ breast cancers get benefit from systemic treatmentBreast Cancer Research and Treatment -doi:10.1007/s10549-019-05508-1Kadri AltundagSpringer USBreast Cancer Research and Treatment